The authorisation may be amended ex officio, suspended or withdrawn by the Director General of the Agence nationale de sécurité du médicament et des produits de santé where it appears :
1° That one or more of the parent products mentioned in the authorisation are harmful under normal conditions of use or are likely to present a risk to human health ;
2° That the conditions of manufacture of the master preparations, or the conditions of preparation, transport and supply of the allergens, either do not comply with the conditions declared in the application which gave rise to the authorisation, or do not comply with the requirements of article R. 4211-6.
Except in emergencies, these decisions to modify, suspend or withdraw may only be taken after the authorisation holder has been given the opportunity to present his observations.